COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 318: Articles 3171-3180  | Next

Clinical evaluation of the Roche distributed SD Biosensor SARS-CoV-2 & Flu A/B Rapid Antigen Test amongst mild symptomatic people during the 2022/2023 winter season.
Igloi, Z., Velzing, J., Koopmans, M., Molenkamp, R.
10.1101/2024.02.05.24302338 — Posted: 2024-02-06
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic Epidemiology
Banga, J., Petros, B. A., Dai, E. Y., Leonelli, A. T., Dobbins, S. T., Messer, K. S., Nathanson, A. B., Capone, A. A., Littlehale, N. A., Appiah-Danquah, V., Dim, S., Moreno, G. K., Crowther, M., Lee, K. A., DeRuff, K. C., MacInnis, B. L., Springer, M., Sabeti, P. C., Stephenson, K. E.
10.1101/2024.02.05.24302348 — Posted: 2024-02-06
SSRI Use During Acute COVID-19 Infection Associated with Lower Risk of Long COVID Among Patients with Depression
Butzin-Dozier, Z., Ji, Y., Deshpande, S., Hurwitz, E., Coyle, J., Shi, J., Mertens, A. N., van der Laan, M., Colford, J. M., Patel, R. C., Hubbard, A., on behalf of the National COVID Cohort Collaborative
10.1101/2024.02.05.24302352 — Posted: 2024-02-06
Natural selection exerted by historical coronavirus epidemic(s): comparative genetic analysis in China Kadoorie Biobank and UK Biobank
Morris, S. C., Lin, K., Millwood, I. Y., Yu, C., Lv, J., Pei, P., Li, L., Sun, D., Davey Smith, G., Chen, Z., Walters, R. G.
10.1101/2024.02.06.579075 — Posted: 2024-02-06
Building Blocks of Understanding: Constructing a Reverse Genetics Platform for studying determinants of SARS-CoV-2 replication.
Olguin-Nava, M., Bohn, P., Hennig, T., Boertlein, C., Gribling-Burrer, A.-S., Schmidt, N., Caliskan, N., Doelken, L., Munschauer, M., Smyth, R. P.
10.1101/2024.02.05.578560 — Posted: 2024-02-06
Second Boost of Omicron SARS-CoV-2 S1 Subunit Vaccine Induced Broad Humoral Immune Responses in Elderly Mice
Kim, E., Khan, M. S., Ferrari, A., Huang, S., Kenniston, T. W., Cassaniti, I., Baldanti, F., Gambotto, A.
10.1101/2024.02.05.578925 — Posted: 2024-02-06
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants
Jain, S., Kumar, S., Lai, L., Linderman, S., Malik, A. A., Ellis, M. L., Godbole, S., Solis, D., Sahoo, M. K., Bechnak, K., Paredes, I., Tanios, R., Kazzi, B., Dib, S. M., Litvack, M. B., Wimalsena, S. T., Ciric, C., Rostad, C., West, R., Teng, I.-T., Wang, D., Kwong, P. D., Rouphael, N., Pinsky, B. A., Douek, D. C., Wrammert, J., Moreno, A., Suthar, M. S.
10.1101/2024.02.03.578771 — Posted: 2024-02-05
Prolonged airway explant culture enables study of health, disease, and viral pathogenesis
Lee-Ferris, R. E., Okuda, K., Galiger, J. R., Schworer, S. A., Rogers, T. D., Dang, H., Gilmore, R., Edwards, C., Nakano, S., Cawley, A. M., Pickles, R. J., Gallant, S. C., Crisci, E., Rivier, L., Hagood, J. S., O'Neal, W. K., Baric, R. S., Grubb, B. R., Boucher, R. C., Randell, S. H.
10.1101/2024.02.03.578756 — Posted: 2024-02-05
DNA Prime-Protein Boost Targeting Conformational Non-RBD Region for Broad Cross-Neutralization
Ma, Y.-F., Chen, K., Xie, B., Zhu, J., He, X., Chen, C., Yang, Y. R., Liu, Y.
10.1101/2024.02.04.578544 — Posted: 2024-02-05
The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming
Paiardi, G., Ferraz, M., Rusnati, M., Wade, R. C.
10.1101/2024.02.05.578888 — Posted: 2024-02-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).